Pyrazolopyrimidines as cyclin-dependent kinase inhibitors

Details for Australian Patent Application No. 2003263071 (hide)

International Classifications

Event Publications

11 December 2003 Complete Application Filed

Priority application(s): 60/421,959 29.10.02 US; 60/408,027 04.09.02 US

13 May 2004 Application Open to Public Inspection

Published as AU-B-2003263071

15 March 2007 Application Accepted

Published as AU-B-2003263071

19 July 2007 Standard Patent Sealed

13 September 2007 Assignment Registered

Pharmacopeia Drug Discovery, Inc.; Schering Corporation The patent has been assigned to Pharmacopeia, Inc.; Schering Corporation

11 October 2012 Application for Amendment

The nature of the amendment is: Amend the Patentee to read Pharmacopeia, Inc. and Merck Sharp & Dohme Corp. . Address for service in Australia - Griffith Hack Level 29, Northpoint 100 Miller Street North Sydney NSW 2060

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.